Organic Revenue Growth
AdaptHealth achieved a 5.1% organic revenue growth in Q3 2025, driven by strength across all four segments.
Sleep and Respiratory Health Growth
Sleep new starts were up nearly 7% from the prior year, recording the highest quarter in two years, and Respiratory Health net revenue increased 7.8%.
Debt Reduction
Reduced debt by $50 million in Q3, bringing year-to-date total debt reduction to $225 million, rapidly approaching a target net leverage ratio of 2.50x.
Improvement in Adjusted EBITDA
Adjusted EBITDA for Q3 2025 was $170.1 million, up 3.5% from the prior year quarter, with a margin increase of 30 basis points.
Strategic Capitated Agreements
Announced a new capitated agreement with a major payer, adding 170,000 lives, and continuing strong performance with existing partnerships.